Under the agreement, Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of ...

COPENHAGEN (Reuters) -Shares in Novo Nordisk rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its ...

The decision comes amid a leadership shakeup at the Danish drugmaker. Current chair Helge Lund and six other independent ...

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...

Novo Nordisk has partnered with Emcure Pharmaceuticals to bring Poviztra, their latest weight-loss medication, to the Indian market. This collaboration builds on Novo Nordisk's prior success with ...

Stocks climbed and Treasuries dropped as hopes for a deal to end the longest US government shutdown lifted sentiment after a ...

Pfizer has clinched a US$10 billion deal to acquire obesity drug developer Metsera, ending a heated bidding war with Danish ...

The Danish pharmaceutical giant is confronting one of its most severe crises in recent memory. A perfect storm of unfavorable ...

A Trump administration deal to slash prices on blockbuster weight-loss drugs such as Wegovy and Zepbound is expected to make ...

In a transformative development for the pharmaceutical industry, Eli Lilly announced on November 6, 2025, a groundbreaking arrangement with the U.S. governme ...

Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.

Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn ...